These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29594936)

  • 21. Correction to: Immediate and delayed hypersensitivity after intra-arterial injection of iodinated contrast media: a prospective study in patients with coronary angiography.
    Sohn KH; Kim GW; Lee SY; Kim HS; Cho SH; Han JK; Kang HR
    Eur Radiol; 2020 Jun; 30(6):3596-3597. PubMed ID: 32072258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear-interaction correction of integrated depth dose in carbon-ion radiotherapy treatment planning.
    Inaniwa T; Kanematsu N; Hara Y; Furukawa T
    Phys Med Biol; 2015 Jan; 60(1):421-35. PubMed ID: 25658006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in Chiba (HIMAC) carbon-ion beams.
    Suzuki M; Kase Y; Yamaguchi H; Kanai T; Ando K
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):241-50. PubMed ID: 10924995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multi-institutional analysis of prospective studies of carbon ion radiotherapy for prostate cancer: A report from the Japan Carbon ion Radiation Oncology Study Group (J-CROS).
    Nomiya T; Tsuji H; Kawamura H; Ohno T; Toyama S; Shioyama Y; Nakayama Y; Nemoto K; Tsujii H; Kamada T
    Radiother Oncol; 2016 Nov; 121(2):288-293. PubMed ID: 27836119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy.
    Kanai T; Endo M; Minohara S; Miyahara N; Koyama-ito H; Tomura H; Matsufuji N; Futami Y; Fukumura A; Hiraoka T; Furusawa Y; Ando K; Suzuki M; Soga F; Kawachi K
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):201-10. PubMed ID: 10219815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction to: All-Trans Retinoic Acid Ameliorates the Early Experimental Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting the Loss of the Blood-Brain Barrier via the JNK/P38MAPK Signaling Pathway.
    Li M; Tian X; An R; Yang M; Zhang Q; Xiang F; Liu H; Wang Y; Xu L; Dong Z
    Neurochem Res; 2018 Aug; 43(8):1703. PubMed ID: 29926353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction to: Draft Genome Sequence of Cyclohexylamine-Degrading Strain Acinetobacter sp. YT-02 Isolated.
    Yan DZ; Gan YT; Zhou H; Liu J; Li X
    Curr Microbiol; 2019 Sep; 76(9):1092. PubMed ID: 29574478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of absorbed dose, quality factor, and dose equivalent in water phantom outside of the irradiation field in passive carbon-ion and proton radiotherapies.
    Yonai S; Kase Y; Matsufuji N; Kanai T; Nishio T; Namba M; Yamashita W
    Med Phys; 2010 Aug; 37(8):4046-55. PubMed ID: 20879566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Author Correction: Drier Climatic Conditions Increase Withanolide Content of Withania coagulans Enhancing its Inhibitory Potential against Human Prostate Cancer Cells.
    Rehman S; Keefover-Ring K; Haq IU; Dilshad E; Khan MI; Akhtar N; Mirza B
    Appl Biochem Biotechnol; 2019 Jul; 188(3):893-895. PubMed ID: 30632062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction to: Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders.
    Mohammadi A; Maleki-Jamshid A; Sanooghi D; Milan PB; Rahmani A; Sefat F; Shahpasand K; Soleimani M; Bakhtiari M; Belali R; Faghihi F; Joghataei MT; Perry G; Mozafari M
    Mol Neurobiol; 2019 Jan; 56(1):319-320. PubMed ID: 29700773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correction to: A case of fatal acebutolol poisoning: an illustration of the potential of molecular networking.
    Le Daré B; Allard S; Bouvet R; Baert A; Allard PM; Morel I; Gicquel T
    Int J Legal Med; 2020 Jan; 134(1):257-258. PubMed ID: 31127372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of ion sources for medical accelerators (invited).
    Muramatsu M; Kitagawa A
    Rev Sci Instrum; 2012 Feb; 83(2):02B909. PubMed ID: 22380341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction to: Development of an efficient perfusion-based protocol for whole-organ decellularization of the ovine uterus as a human-sized model and in vivo application of the bioscaffolds.
    Daryabari SS; Kajbafzadeh AM; Fendereski K; Ghorbani F; Dehnavi M; Rostami M; Garajegayeh BA; Tavangar SM
    J Assist Reprod Genet; 2019 Jun; 36(6):1293. PubMed ID: 31165388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction to: Development of an efficient perfusion-based protocol for whole-organ decellularization of the ovine uterus as a human-sized model and in vivo application of the bioscaffolds.
    Daryabari SS; Kajbafzadeh AM; Fendereski K; Ghorbani F; Dehnavi M; Rostami M; Azizi Garajegayeh B; Tavangar SM
    J Assist Reprod Genet; 2019 Oct; 36(10):2191. PubMed ID: 31522369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction to: Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH.
    Gall H; Vachiéry JL; Tanabe N; Halank M; Orozco-Levi M; Mielniczuk L; Chang M; Vogtländer K; Grünig E
    Lung; 2018 Jun; 196(3):313. PubMed ID: 29616325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction to: Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura.
    Azoulay E; Bauer PR; Mariotte E; Russell L; Knoebl P; Martin-Loeches I; Pène F; Puxty K; Povoa P; Barratt-Due A; Garnacho-Montero J; Wendon J; Munshi L; Benoit D; von Bergwelt-Baildon M; Maggiorini M; Coppo P; Cataland S; Veyradier A; Van de Louw A;
    Intensive Care Med; 2020 Mar; 46(3):570-571. PubMed ID: 31965263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience.
    Kamada T; Tsujii H; Blakely EA; Debus J; De Neve W; Durante M; Jäkel O; Mayer R; Orecchia R; Pötter R; Vatnitsky S; Chu WT
    Lancet Oncol; 2015 Feb; 16(2):e93-e100. PubMed ID: 25638685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction to: Real‑world experience with dalbavancin therapy in gram‑positive skin and soft tissue infection, bone and joint infection.
    Tobudic S; Forstner C; Burgmann H; Lagler H; Steininger C; Traby L; Vossen MG; Winkler S; Thalhammer F
    Infection; 2020 Feb; 48(1):149. PubMed ID: 31741186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Density of hydroxyl radicals generated in an aqueous solution by irradiating carbon-ion beam.
    Matsumoto K; Ueno M; Nakanishi I; Anzai K
    Chem Pharm Bull (Tokyo); 2015; 63(3):195-9. PubMed ID: 25757490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correction to: Is liver lesion characterisation by simplified IVIM DWI also feasible at 3.0 T?
    Mürtz P; Pieper CC; Reick M; Sprinkart AM; Schild HH; Willinek WA; Kukuk GM
    Eur Radiol; 2019 Aug; 29(8):4524-4525. PubMed ID: 31115624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.